2012-11-09T09:02:28-06:00 2011-12-31 541029635 THOMPSON GREENSPON & CO P C CPA'S 4035 RIDGE TOP RD SUITE 700 FAIRFAX VA 22030 990 2011-01-01 131772100 NATIONAL PHARMACEUTICAL COUNCIL INC NATI 2028272100 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 PATRICIA ADAMS 2028272100 2012-11-08 1 CHARLES F HELME III CPA P00118452 7033858888 2011 2016-02-24 21:20:13Z X PATRICIA ADAMS 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 24783449 0 X SEE SCHEDULE O X 1953 NY TO SPONSOR AND CONDUCT SCIENTIFIC ANALYSES OF APPROPRIATE USE OF PHARMACEUTICALS AND THE CLINICAL AND ECONOMICAL VALUE OF INNOVATION. 16 16 14 16 0 0 0 0 6939053 6158267 164510 1614366 -8991 -7849 7094572 7764784 0 0 0 0 3422035 6516457 0 0 0 3103438 3627337 6525473 10143794 569099 -2379010 19905481 18690406 5457616 6912709 14447865 11777697 TO SPONSOR, PARTICIPATE IN AND PROMOTE THE SCIENTIFIC ANALYSES OF THE APPROPRIATE USE OF PHARMACEUTICALS AND THE CLINICAL AND ECONOMIC VALUE OF IMPROVED HEALTH OUTCOMES THROUGH PHARMACEUTICAL INNOVATION. 0 0 THE NATIONAL PHARMACEUTICAL COUNCIL SPONSORS AND CONDUCTS SCIENTIFIC ANALYSES OF THE APPROPRIATE USE OF PHARMACEUTICALS AND THE CLINICAL AND ECONOMIC VALUE OF INNOVATION. THE ORGANIZATION'S STRATEGIC FOCUS IS ON EVIDENCE-BASED MEDICINE (EBM) FOR HEALTH CARE DECISION-MAKING TO ENSURE THAT PATIENTS HAVE ACCESS TO HIGH-QUALITY CARE. ALL ACTIVITIES UNDERTAKEN BY THE COUNCIL RELATE TO THESE FUNCTIONS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 8 0 1 14 1 0 0 0 0 1 1 0 X 16 16 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X THE COUNCIL 2028272100 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 JACK BAILEY 1.00 X 0 0 0 JOHN BARDI 1.00 X 0 0 0 KEVIN RIGBY 5.00 X X 0 0 0 MARIE-CAROLINE SAINPY 1.00 X 0 0 0 JON CONGLETON 1.00 X 0 0 0 ANTHONY HOOPER 1.00 X 0 0 0 JOHN GARGIULO 1.00 X 0 0 0 JEROME DURSO 1.00 X 0 0 0 JEFF HUTH 1.00 X 0 0 0 RICHARD FANTE 5.00 X X 0 0 0 TODD JOHNSON 1.00 X 0 0 0 NORMAN ROSENTHAL 1.00 X 0 0 0 JOHN ROTONDO 1.00 X 0 0 0 JACQUELINE NELSON 1.00 X 0 0 0 JEFF JONAS 1.00 X 0 0 0 DAVID MARTIN 1.00 X 0 0 0 DANIEL LEONARD 40.00 X 1090219 0 24154 PATRICIA ADAMS 40.00 X 367860 0 19549 ROBERT DUBOIS 40.00 X 429301 0 970 KIMBERLY WESTRICH 40.00 X 198839 0 23893 KATHRYN GLEASON 40.00 X 122630 0 8554 JENNIFER GRAFF 40.00 X 204859 0 19066 ANDREA HOFELICH 40.00 X 134769 0 24082 2548477 0 120268 7 0 1 0 OUTCOME PO BOX 983022 BOSTON MA 022983022 CONSULTING 362036 CENTER FOR MEDICAL TECHNOLOGY POLICY 401 EAST PRATT STREET SUITE 631 BALTIMORE MD 21202 CONSULTING 350756 HEALTH AFFAIRS 7500 OLD GEORGETOWN RD SUITE 600 BETHESDA MD 20814 CONSULTING 300000 COVINGTON & BURLINGTON 1201 PENNSYLVANIA AVE NW WASHINGTON DC 200042401 LEGAL SERVICES 271356 CERNER CORPORATION PO BOX 412702 KANSAS CITY MO 64141 CONSULTING 231462 5 MEMBERSHIP DUES 900099 6158267 6158267 6158267 328111 328111 115937 123786 -7849 -7849 -7849 15581134 2600000 15690958 1203921 -109824 1396079 1286255 1286255 7764784 6158267 0 1606517 2668745 303043 112718 3327676 104275 238412 59084 57395 193101 108139 61624 235277 115046 97632 62 40341 26508 PROJECTS/SPECIAL STUDIE 2370682 ENTERTAINMENT 12624 SUBSCRIPTION 10751 PENALTIES 659 10143794 95415 -163284 1956831 3416717 92679 336276 368083 287829 1147248 80254 16600371 14923784 12937 96659 19905481 18690406 622029 524957 1921360 1194158 2914227 5193594 5457616 6912709 X 14111793 11477094 336072 300603 14447865 11777697 19905481 18690406 X -2379010 -291158 X X 0 1 1 X 0 1 1 0 317702 239501 78201 50381 48328 2053 80254 PENSION COST LIABILITY 4392072 NONQUALIFIED, DEFERRED COMPENSATION LIABILITY 801522 5193594 7764784 10143794 -2379010 -291158 -291158 -2670168 7458819 -291158 42588 -248570 7707389 57395 57395 7764784 10093518 7119 7119 10086399 57395 57395 10143794 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: PART X, LINE 2: AS OF DECEMBER 31,2011 AND 2010, THE COUNCIL HAS NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS AND NO INTEREST OR PENALTIES HAVE BEEN RECORDED IN THE ACCOMPANYING FINANCIAL STATEMENTS RELATED TO UNCERTAIN TAX POSITIONS. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL REVENUE-DEPRECIATION-$7119 RELEASED FROM RESTRICTIONS-$35469 PART XII, LINE 4B - OTHER ADJUSTMENTS: BANK CHARGES AND INVESTMENT FEES-$57,395 PART XIII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES, DEPRECIATION-$7119 PART XIII, LINE 4B - OTHER ADJUSTMENTS: BANK CHARGES-$57,395 X 1 1 X X X 0 1 0 DANIEL LEONARD 683383 0 247000 0 159836 0 0 0 24154 0 1114373 0 144469 0 PATRICIA ADAMS 286872 0 34905 0 46083 0 0 0 19549 0 387409 0 39277 0 ROBERT DUBOIS 385585 0 43200 0 516 0 0 0 970 0 430271 0 0 0 KIMBERLY WESTRICH 176763 0 21956 0 120 0 0 0 23893 0 222732 0 0 0 JENNIFER GRAFF 182795 0 21956 0 108 0 0 0 19066 0 223925 0 0 0 ANDREA HOFELICH 120233 0 14428 0 108 0 0 0 24082 0 158851 0 0 0 PART I, LINE 1A PATRICIA ADAMS AND DANIEL LEONARD RECEIVE GROSS-UP PAYMENTS TO THE NONQUALIFIED RETIREMENT PLAN AVAILABLE TO OFFICERS. THESE PAYMENTS ARE INCLUDED IN THEIR TAXABLE COMPENSATION WHEN PAID. PART I, LINE 4B SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN - PATRICIA ADAMS-$45,291 DANIEL LEONARD-$159,656 FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 IS REVIEWED BY THE TREASURER AND THE VICE PRESIDENT OF BUSINESS OPERATIONS AND EXTERNAL AFFAIRS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY COVERS ALL MEMBERS OF THE BOARD, THE OFFICERS AND STAFF AND IS MONITORED BY ANNUAL WRITTEN INFORMATION QUESTIONAIRES FROM THE PRESIDENT WHICH ARE REVIEWED AND MAINTAINED BY THE VICE PRESIDENT OF BUSINESS OPERATIONS AND EXTERNAL AFFAIRS. THE BOARD OFFICERS REVIEW EACH TRANSACTION TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF ANY POTENTIAL OR ACTUAL CONFLICTS ARE INDENTIFIED, THE PERSON DETERMINED TO HAVE A CONFLICT IS RECUSED FROM DELIBERATIONS, VOTING OR ANY ACTIONS RELATED TO THE MATTER. THE IDENTIFIED CONFLICTS WOULD BE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS FOR DETERMINING COMPENSATION OF THE FOLLOWING PERSONS INCLUDES A REVIEW AND APPROVAL BY THE CHAIRMAN OF THE BOARD, WHO IS AN INDEPENDENT BOARD MEMBER ELECTED ANNUALLY ON A ROTATING BASIS. COMPARABILITY DATA USED IN THE REVIEW PROCESS IS OBTAINED FROM PUBLIC SOURCES, RECRUITERS, AND OTHER HUMAN RESOURCES PROFESSIONALS. THE AUDIT AND BUDGET COMMITTEE APPROVES TOTAL SALARIES AS APPROVED BY THE CHAIRMAN. THE COMPENSATION DETERMINATION PROCESS APPLES TO THE FOLLOWING OFFICE/POSITION AND THE MOST RECENT YEAR FOR WHICH THE PROCESS WAS UNDERTAKEN FOR EACH IS IDENTIFIED. THE CHAIRMAN OF THE BOARD REVIEWS AND APPROVES THE SALARY FOR THE PRESIDENT. THE PRESIDENT REVIEWS AND APPROVES ALL OTHERS WITHIN THE BUDGET APPROVED BY THE AUDIT AND BUDGET COMMITTEES. ALL SALARIES WERE REVIEWED AND APPROVED IN 2011. FORM 990, PART VI, SECTION C, LINE 19 THE NATIONAL PHARMACEUTICAL COUNCIL DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED LOSSES ON INVESTMENTS: -291,158. FORM 990, PART XII, LINE 2C PROCESS HAS NOT CHANGED. FORM 990, PAGE ONE, HEADING J, WEBSITES: WWW.RXROI.ORG WWW.NPCNOW.ORG WWW.YOURPHARMACYBENEFIT.ORG